Identification and development of novel antifibrotic agents.
The second IBC meeting on fibrosis was held in Washington DC on April 28 - 29. Presentations covered a broad range of topics, including investigation of basic mechanisms that underlie the causes of fibrosis to novel therapeutic methods. Although the investigative area is in an early stage, much progress has been made concerning the development of a uniform mechanism for fibrotic disorders. It is anticipated that significant gains in the understanding of the cellular and molecular base for these disorders will lead to the development of effective therapeutic approaches in the near future.